Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
16,798
-
Share change
-
-15,392
-
Total reported value
-
$88,526
-
Price per share
-
$5.25
-
Number of holders
-
15
-
Value change
-
-$90,493
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of TITAN PHARMACEUTICALS INC - COM NEW (TTNP) as of Q3 2024
As of 30 Sep 2024,
TITAN PHARMACEUTICALS INC - COM NEW (TTNP) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,798 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, Tower Research Capital LLC (TRC), MCF Advisors LLC, BANK OF AMERICA CORP /DE/, GROUP ONE TRADING LLC, OSAIC HOLDINGS, INC., MORGAN STANLEY, Global Wealth Strategies & Associates, and Cape Investment Advisory, Inc..
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.